PT  - JOURNAL ARTICLE
AU  - Kim, Hyunju
AU  - Paul, Ayan
TI  - Automated Contact Tracing: a game of big numbers in the time of COVID-19
AID  - 10.1101/2020.04.22.20071043
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.22.20071043
4099  - http://medrxiv.org/content/early/2020/09/13/2020.04.22.20071043.short
4100  - http://medrxiv.org/content/early/2020/09/13/2020.04.22.20071043.full
AB  - One of the more widely advocated solutions for slowing down the spread of COVID-19 has been automated contact tracing. Since proximity data can be collected by personal mobile devices, the natural proposal has been to use this for automated contact tracing providing a major gain over a manual implementation. In this work, we study the characteristics of voluntary and automated contact tracing and its effectiveness for mapping the spread of a pandemic due to the spread of SARS-CoV-2. We highlight the infrastructure and social structures required for automated contact tracing to work. We display the vulnerabilities of the strategy to inadequate sampling of the population, which results in the inability to sufficiently determine significant contact with infected individuals. Of crucial importance will be the participation of a significant fraction of the population for which we derive a minimum threshold. We conclude that relying largely on automated contact tracing without population-wide participation to contain the spread of the SARS-CoV-2 pandemic can be counterproductive and allow the pandemic to spread unchecked. The simultaneous implementation of various mitigation methods along with automated contact tracing is necessary for reaching an optimal solution to contain the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by a grant from the John Templeton Foundation. The opinions/conclusions presented in this publication are those of the author(s) and do not necessarily reflect the views of the John Templeton FoundationAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data necessary to reproduce our results are in the paper or the references therein.